Triple massive-dose drug therapy in combined treatment of advanced ovarian carcinoma.
D002277:Carcinoma / Q000532:radiotherapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008134:Long-Term Care; D008727:Methotrexate / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011033:Podophyllin; D011379:Prognosis
D003520:Cyclophosphamide; D011033:Podophyllin; D008727:Methotrexate